PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.
about
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaDiagnosis of hepatocellular carcinoma.Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcomaEvaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinomaSorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1The association of HMGB1 gene with the prognosis of HCC.The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.Rapid and early α-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma.Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.Ultrasensitive Luminescent In Vitro Detection for Tumor Markers Based on Inorganic Lanthanide Nano-Bioprobes.AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resectionPrevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion.Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.MicroRNA-125b suppresses the migration and invasion of hepatocellular carcinoma cells by targeting transcriptional coactivator with PDZ-binding motif.Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.The 4th Asia-Pacific Primary Liver Cancer Expert MeetingClinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.An isolated metachronous metastasis to the adrenal gland from a pancreatic neuroendocrine tumor: A case report.Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong
P2860
Q26999045-021FC710-ED86-42CF-A39D-E0DC71A6C29DQ28392783-B430E677-2C7B-4CF1-87B6-035F91784D7CQ28394414-6C4EA098-4247-47AE-9C94-54D14D75112DQ30490554-DC873730-DEF9-408C-8C26-288A332403EAQ33775228-5B279AAE-5C57-4744-9646-6314779D79C6Q34647652-A66D322C-D8D0-456A-BA8F-A428FD1E279EQ35080145-48FC1691-0903-4D32-99A1-031B1AB19A03Q35097379-8302064B-176F-46C0-B70A-C9733335A8EFQ35106665-151EF725-EBCB-4F0F-B6D6-9DBAE67116CFQ35177271-9695EE4D-71BB-4A13-B850-15935B78E85DQ35753801-0E1C35AC-A5D0-464B-AAD6-F8A173E860CEQ35987232-93F9CCFC-9CCD-463E-8CD4-55D98762136EQ36082480-DBA7295C-2284-4158-8BAB-F9DBB8A60FF0Q37404644-20E04283-9272-403F-8DCC-0BF93EE40358Q37425226-E32406B9-3B2F-4F6B-8900-2A5F2D2A6C2FQ37568646-ACBD638F-D553-4CA4-BED0-4443F69E015BQ37578500-678F18C9-7DE6-41C5-BBBD-0F619760DDD4Q37687816-F1976CB9-A6ED-41A0-BAF0-02106A87FB9FQ37972806-5B937130-1C0C-4386-B677-9DE92BDA2379Q38120063-480B2890-C2EC-4F3B-8350-7FA73CA11DF2Q38374068-BDF460B4-B8CB-45CA-9C86-6ECBE5936300Q38692450-CD8316C5-47ED-4F58-8891-C093E258E642Q38849845-0BB33888-4C0E-428C-8530-D1F06D6001C7Q39556002-437B1B13-0FB2-409A-8FD5-1E605FBF82C2Q40572955-4893F948-18CD-4E17-80F1-7B7D1ED00AA2Q42270431-4532A73C-2BC8-4AC2-B605-FF898B8DA8A0Q43183158-29795BFF-48A1-4BBD-B3DE-DFA456B7F492Q43714851-3B9D5F5A-6AC3-460C-8E0F-276870806FE4Q47121517-12E8FFE0-BFF7-43B6-9AFD-E8EB5F40D502Q47911866-E1281206-414F-44B6-9CE3-4251CB697DC9Q49197751-1983175D-37AD-444D-9F58-4B3628958D0FQ57066918-185BD983-AEED-47A8-8E30-2136EEBDA316
P2860
PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@ast
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@en
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@nl
type
label
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@ast
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@en
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@nl
prefLabel
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@ast
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@en
PIVKA-II is a useful tumor mar ...... noma after surgical resection.
@nl
P2093
P2860
P50
P356
P1433
P1476
PIVKA-II is a useful tumor mar ...... inoma after surgical resection
@en
P2093
Chae Yoon Chon
Do Young Kim
Ja Kyung Kim
Jong Won Choi
Yong Han Paik
Young Jun Youn
P2860
P356
10.1159/000111707
P478
72 Suppl 1
P577
2007-12-13T00:00:00Z